Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2018 / N 3

Выявление фосфорилированного α-синуклеина в биопсийном материале слюнных желез при болезни Паркинсона
В.Б. Соболев, Р.М. Худоерков, Р.Р. Богданов, И.А. Давыдов, С.Ю. Борисова, С.Н. Иллариошкин

References

1. Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL. Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? Acta Neuropathologica 2013 May;125:753-69.
2. Malek N, Swallow D, Grosset KA, Anichtchik O, Spillantini M, Grosset DG. Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease – a systematic review. Acta Neurologica Scandinavica 2014 Aug;130:59-72.
3. Ninkina N, Peters OM, Connor-Robson N, Lytkina O, Sharfeddin E, Buchman VL. Contrasting effect of alpha-synuclein and gamma-synuklein on the phenotype of cysteine string protein alpha (CSPa) null mutant mice suggest distinct function of these proteins in neuronal synapses. Journal of Biological Chemistry 2012 Dec;287(53):44471-7.
4. Uéda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1993 Dec;90(23):11282-6.
5. Beyer K, Ariza A. Alpha-synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Molecular Neurobiology 2013 Apr;47(2):509-24.
6. Levitan K, Chereau D, Cohen SI, Knowles TP, Dobson CM, Fink AL, Anderson JP, Goldstein JM, Millhauser GL. Conserved C-terminal charge exerts a profound influence on the aggregation rate of alpha-synuclein. Journal of Molecular Biology 2011 Aug;411(2):329-33.
7. Uversky VN. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. Journal of Neurochemistry 2007 Oct;103(1):17-37.
8. Bernstein SL, Liu D, Wyttenbach T, Bowers MT, Lee JC, Gray HB, Winkler JR. Alpha-synuclein: stable compact and extended monomeric structures and pH dependence of dimer formation. Journal of the American Society for Mass Spectrometry 2004 Oct;15(10):1435-43.
9. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. The precursor protein of non-A beta component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995 Feb;14(2):467-75.
10. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neuroscience Letters 2006 Mar;396(1):67-72.
11. Braak H, Del Tredici K. Neuropathological staging of brain pathology in sporadic Parkinson’s disease: separating the wheat from the chaff. Journal of Parkinson's Disease 2017;7(Suppl 1):S71-S85.
12. Bennett MC. The role of alpha-synuclein in neurodegenerative diseases. Pharmacology & Therapeutics 2005 Mar;105(3):311-31.
13. Breydo L, Wu JW, Uversky VN. Alpha-synuclein misfolding and Parkinson’s disease. Biochimica et Biophysica Acta 2012 Feb;1822(2):261-85.
14. Jellinger KA. Neuropathological spectrum of synucleinopathies. Movement Disorders 2003 Sep;18(Suppl 6):S2-12.
15. Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease? BMC Medicine 2018 Mar;16(1):34.
16. Forno LS. Neuropathology of Parkinson’s disease. Journal of Neuropathology and Experimental Neurology 1996 Mar;55(3):259-72.
17. Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S ,Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. The World Journal of Biological Psychiatry 2018 Jun;19(4):244-328.
18. Caviness JN. Presymptomatic Parkinson’s disease: the Arizona experience. Parkinsonism & Related Disorders 2012 Jan;18(Suppl 1):S203-6.
19. Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG; Arizona Parkinson's Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathologica 2010 Jun;119(6):689-702.
20. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P. Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PLoS One 2010 Sep;5(9):e12728.
21. Pouclet H, Lebouvier T, Coron E, Des Varannes SB, Neunlist M, Derkinderen P. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson’s disease. Neurogastroenterology and Motility 2012 Apr;24(4):e202-5.
22. Cersósimo MG, Perandones C, Micheli FE, Raina GB, Beron AM, Nasswetter G, Radrizzani M, Benarroch EE. Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson’s disease patients. Movement Disorders 2011 Jan;26(1):188-90.
23. Salkov VN, Khudoyerkov RM, Voronkov DN, Ivanov MV. Morphometry of glial cells in the human substantia nigra in ageing and Parkinson disease. Clinical And Experimental Morphology 2017;4(24):26-30 (In Russian).
24. Mu L, Sobotka S, Chen J, Su H, Sanders I, Nyirenda T, Adler CH, Shill HA, Caviness JN, Samanta JE, Sue LI, Beach TG; Arizona Parkinson’s Disease Consortium. Parkinson disease affects peripheral sensory nerves in the pharynx. Journal of Neuropathology and Experimental Neurology 2013 Jul;72(7):614-23.
25. Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. The Journal of Neuroscience 2005 Jun;25(25):6016-24.
26. Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K. The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy. Journal of Neural Transmission 2006 Oct;113(10):1435-9.
27. Nakai M, Fujita M, Waragai M, Sugama S, Wei J, Akatsu H, Ohtaka-Maruyama C, Okado H, Hashimoto M. Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson’s disease, in erythropoietic lineage. Biochemical and Biophysical Research Communications 2007 Jun;358(1):104-10.
28. Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, Samii A, Snapinn KW, Tsuang DW, Yearout D, Zhang J, Payami H, Zabetian CP. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology 2010 Nov;67(11):1350-6.
29. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proceedings of the National Academy of Sciences of the United States of America 1998 May;95(11):6469-73.
30. Goedert M. Neurodegeneration. Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled Ab, tau, and a-synuclein. Science 2015 Aug;349(6248):1255555.
31. Doppler K, Ebert S, Uçeyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C. Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology. Acta Neuropathologica 2014 Jul;128(1):99-109.
32. Michell AW, Luheshi LM, Barker RA. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson’s disease. Neuroscience Letters. Supplement 2005 Jun;381(3):294-8.
33. Zange L, Noack C, Hahn K, Stenzel W, Lipp A. Phosphorylated a-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy. Brain 2015 Aug;138(Pt 8):2310-21.
34. Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A, Hähner A, Reichmann H, Hummel T. Biopsies of olfactory epithelium in patients with Parkinson’s disease. Movement Disorders 2009 Apr;24(6):906-14.
35. Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A. a-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology. Brain Structure & Function 2014 Sep;219(5):1513-26.
36. Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K. Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Experimental Neurology 2002 Jul;176(1):98-104.
37. Viktorov IV, Proshin SS. Application of isopropyl alcohol in histological methods: dehydration and filling of tissue into paraffin, processing of paraffin sections. Bulletin of Experimental Biology and Medicine 2003;136(7):119-20 (In Russian).
38. Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathologica 2010 Jun;119(6):703-13.
39. Fedotova EYu, Chechetkin AO, Abramycheva NYu, Chigaleychik LA, Baziyan BKh, Ponomareva ТА, Alexeeva NS, Fedin PA, Kravchenko MA, Varakin YuYa, Ivanova-Smolenskaya IA, Illarioshkin S.N. Identification of people at the latent stage of Parkinson’s disease (the PARKINLAR study): first results and algorithm optimization. SS Korsakov 2015;115(6):4-11 (In Russian).
40. Illarioshkin SN, Chechetkin AO, Fedotova EYu. Transcranial sonography and extrapyramidal diseases. Moscow: ATMO; 2014. 176 p. (In Russian).
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]